Amgen (KANJINTI)
(https://kanjinti.com) 📸 Data Snapshot: May 31, 2026Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
A significant technical authority gap exists as the site contains null schema_json data across all pages, failing to utilize Organization or Drug schema to verify its entity status. Furthermore, while it mentions ‘Amgen Oncology representatives,’ it lacks named medical experts or Person schema for its leadership, relying entirely on corporate brand authority. This lack of structured digital identity contrasts with the high-stakes nature of the medical claims being made.
The performance claims are largely grounded in regulatory approval (‘FDA approved with highly similar safety and efficacy’), which minimizes the disconnect. The only notable fluff-to-fact gap is the claim of ‘personalized support,’ which leads to standard downloadable PDFs and generic contact forms rather than evidence of a truly personalized experience. Most other claims, like ‘zero supply shortages,’ are stated as historical facts rather than future-looking marketing fluff.
Identity & Authority is read from the structured data first: whether the site declares who it is in machine-readable schema, with verifiable identity links. Below is the schema captured per page, then the external proof links that support (or fail to support) that identity.
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps
🛡️ Trust Signals — external proof links that back the declared identity
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 0 | 0 |
| /patient-resources/what-is-kanjinti/ | 1 | 0 |
| /hcp/biosimilar-expertise/ | 0 | 0 |
| /hcp/dosing/ | 0 | 0 |
This page presents a snapshot of public data from Amgen (KANJINTI), captured on May 31, 2026, to show how machine logic reads Identity & Authority signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to Amgen (KANJINTI): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://kanjinti.com to view the most current version of its content and see directly what this company is about and what it offers.